News & Noteworthy

Apr 15, 2009

IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma.

see all news >

Programs & Resources

Patient Resources Patient Resources

Information on sarcoma subtypes, treatments, clinical trials, and other important resources for sarcoma patients and families.

Patient Registry Sarcoma Patient Registry

Information on the Sarcoma Patient Registry. If you are diagnosed with sarcoma, please consider joining the Registry.

Research Grants Research Grants

Information on applying for a sarcoma research grant, current research funded by the SFA, and past research grants.